Repligen Upstream Bioprocessing

  1. Exploring Perfusion Technology For Virus Manufacturing Process Intensification 1/23/2026

    Perfusion cell culture technology supports high cell densities and product yields for viral vaccine manufacturing, offering a reliable way to produce high-quality cells at a commercial scale.

  2. Disruptive Technologies Transforming Upstream Process Intensification 1/22/2026

    The demand for complex biologics is driving the need for intensified cell culture technologies. Perfusion using ATF has emerged as a leading solution to increase cell density and productivity.

  3. Breaking Productivity Barriers In Upstream Bioprocessing 1/21/2026

    Learn about innovative cell retention technology that supports continuous bioprocessing through perfusion cell culture, allowing for longer run times, higher product yields, and reduced costs. 

  4. Simpler, Faster, Cheaper Advanced Therapy Manufacturing 1/20/2026

    Discover how TFDF-based perfusion technology boosts lentiviral vector production by over 10-fold, slashes costs, and accelerates the commercialization of CAR-T and other advanced cell therapies.

  5. The Proven, Practical Gateway To Upstream Process Intensification 11/18/2025

    N-1 perfusion enables higher inoculum densities, faster production, and reduced costs without altering fed-batch processes. Explore a practical path to intensification for biologics manufacturers.

  6. Unlock Viral Vector Yield And Efficiency With Upstream Intensification 8/26/2025

    Streamline viral vector manufacturing with perfusion technologies that reduce costs and improve scalability. Discover how a tangential flow depth filtration system enhances yield and quality.

  7. Enabling Advanced Bioprocessing: Solutions That Challenge The Status Quo 8/20/2025

    Discover how innovative solutions can reduce production time, cut costs, and improve yields to ensure exceptional product quality at every stage of biologic drug development.

  8. Applying The Lessons From mAbs Production To Advanced Therapeutics 5/21/2025

    Continuous bioprocessing is revolutionizing biotherapeutic manufacturing. Gain expert insights about cutting-edge innovations in monoclonal antibody production that enable scalable solutions for next-gen therapies.

  9. Advanced Technology Platform For Stem Cell-Derived Exosomes 5/15/2025

    Demand for EVs is rising due to their therapeutic promise. Explore two scalable platforms that address production challenges to support EVs' expanding clinical and commercial applications.

  10. Extracellular Vesicle Isolation From Conditioned Media 5/15/2025

    Explore a scalable, sterile solution for isolating extracellular vesicles (EVs) in exosome therapeutics to enhance yield, purity, and commercial viability through innovative filtration technology.